leisure time -WSS

leisure time

author：leisure time 2025-09-29 19:05:18 - browse：19369

Since the early days of the pandemic, long Covid has haunted us: Even a mild acute infection might leave you with life-altering consequences. And for many, that has, sadly, turned out to be the case. While research suggests long Covid rates are falling, it still affects millions. In June 2023, 6% of Americans reported experiencing long Covid.

But what if long Covid isn’t the right way to think about what they are going through?

On this episode of the First Opinion Podcast, I spoke with Steven Phillips and Michelle A. Williams, authors of a recent First Opinion essay titled, “Long Covid is a new name for an old syndrome.” Steven is a Global Virus Network board member and vice president for science and strategy at the COVID Collaborative; Michelle is the former dean and current Joan and Julius Jacobson professor of epidemiology and public health at the Harvard T.H. Chan School of Public Health.

“Michelle and I have come up with basically a new paradigm that says long Covid is really an old disease, and the more you do deep dives into the history of chronic fatigue syndrome and post-infectious fatigue syndromes, the more you realize that not only are there similarities, but the level of congruence between the two is strikingly high,” Steven said.

The purpose of this new paradigm is to “break the logjam” of the current long Covid discourse and “to try to provide a framework whereby people would think about long Covid in a different way in a way that would be more productive,” Michelle told me.

We discussed the history of post-infectious disease syndrome, what rethinking long Covid might mean for research, and the ways the health care system fails chronically ill patients.

Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Spotify, Google Play, or wherever you get your podcasts.

Previous article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
Next article： How AI can help patients find reliable information about doctors

hotspot

WSS

Is there really a nursing shortage in the U.S.?

At ASCO, pharma leaders speak of advances in 'smart bomb' drugs

ASCO 2024: 'Reassuring' Corbus data on ADC bladder cancer drug

Roche acquires Telavant from Roivant, adding experimental IBD treatment

Innovation in antibiotics is ailing. 'Brain drain' may kill it

The problems with dementia villages

focus

leisure time

Wikipedia

Alkermes shareholders re

Is there really a nursing shortage in the U.S.?

Sports medicine is finally prioritizing gender equality

ASCO 2024: 'Reassuring' Corbus data on ADC bladder cancer drug

ChatGPT in medicine: STAT answers readers' burning questions

Harvard's Jason Buenrostro wins MacArthur grant for genetics work

Continuity nursing helped my family in our darkest PICU moments

At ASCO, pharma leaders speak of advances in 'smart bomb' drugs

Wildfire smoke exposes gaps in outdoor worker protections

STAT Readout Newsletter: Biotech news today

entertainment

With trial win, GSK could get blood cancer drug back on market

STAT Readout: Friday, Oct. 20 biotech updates

Ultragenyx gene therapy for rare liver ailment succeeds in late

The Pandemic Treaty must support building strong health systems

ASCO Daily Recap: Safety data from Novartis, survival from Pfizer

Smaller biotechs seek to piggyback on weight loss drug boom

focus

knowledge

hotspot

hotspot